Print
Improving outcomes for young women with breast cancer: fertility and childbearing issues
https://www.facingourrisk.org/XRAY/outcomes-young-women-breast-cancer-childbearing
Fertility issues and family planning decisions are prominent concerns for young women with breast cancer. This XRAYS looks at Dr. Ann Partridge’s presentation at the 2018 San Antonio Breast Cancer symposium. Her talk, “Breast cancer in young women: Understanding differences to improve outcomes," focused on initial findings from the Young Women's Breast Cancer Study. Dr. Partridge’s research continues in the currently enrolling POSITIVE trial which tests whether women can safely interrupt adjuvant endocrine therapy in order to get pregnant. (1/7/19)
Questions To Ask Your Health Care Provider
- Is it safe for me to become pregnant after treatment for breast cancer?
- I have had breast cancer and I am interested in having children. What factors should I consider?
- How might my cancer treatment affect my future ability to have children?
- Are there ways to preserve my fertility? How might they impact my risk of cancer recurrence?
- Before I start treatment, is there anything that I should know about preserving my fertility?
- I am experiencing anxiety or distress, can you refer me to a mental health expert?
Open Clinical Trials
The following research studies related to fertility preservation are enrolling patients.
Fertility preservation studies for women
Fertility preservation for men
- NCT02972801: Testicular Tissue Cryopreservation for Fertility Preservation. Testicular tissue cryopreservation is an experimental procedure involving testicular tissue that is retrieved and frozen. This technique is reserved for young male patients, with the ultimate goal that their tissue may be used in the future to restore fertility when experimental techniques emerge from the research pipeline.
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.